Sp716

PANEL DISCUSSION

Date
May 20, 2024

Presenters

Speaker Image for Baha Moshiree
Atrium Health
Speaker Image for Douglas Drossman
Drossman Gastroenterology
Speaker Image for Anthony Lembo
Cleveland Clinic

Tracks

Related Products

Thumbnail for EFFICACY OF A NOVEL, DISCRIMATORY P-VALUE BASED, IGG ASSAY-GUIDED ELIMINATION DIET BY IBS SUBTYPE: RESULTS FROM A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, SHAM-CONTROLLED STUDY
EFFICACY OF A NOVEL, DISCRIMATORY P-VALUE BASED, IGG ASSAY-GUIDED ELIMINATION DIET BY IBS SUBTYPE: RESULTS FROM A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, SHAM-CONTROLLED STUDY
INTRODUCTION: There is a lack of data on the efficacy of dietary therapies by IBS subtype (IBS-D, IBS-C, and IBS-M)…
Thumbnail for Irritable Bowel Syndrome Clinical
Irritable Bowel Syndrome Clinical
TREATMENT WITH THE HISTAMINE 1 RECEPTOR ANTAGONIST EBASTINE FOR NON-CONSTIPATED IRRITABLE BOWEL SYNDROME: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL
Thumbnail for Novel Findings in Patient Reports and Clinical Outcomes
Thumbnail for PANEL DISCUSSION